80 FR 18244 - Clinical Laboratory Improvement Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 64 (April 3, 2015)

Page Range		18244-18244
FR Document		2015-07639

Federal Register, Volume 80 Issue 64 (Friday, April 3, 2015)

[Federal Register Volume 80, Number 64 (Friday, April 3, 2015)]
[Notices]
[Page 18244]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-07639]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee

    Correction: This notice was published in the Federal Register on 
March 24, 2015, Volume 80, Number 56, Pages 15621-15622. The times and 
dates should read as follows:
    Times and Dates: 12:30 p.m.--5:00 p.m., April 15, 2015; 8:30 a.m.--
12:00 p.m., April 16, 2015.

Contact Person for Additional Information:  Nancy Anderson, Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Programs, 
Standards, and Services, Center for Surveillance, Epidemiology and 
Laboratory Services, Office of Public Health Scientific Services, CDC, 
1600 Clifton Road NE., Mailstop F-11, Atlanta, Georgia 30329-4018; 
telephone (404) 498-2741; or via email at [email protected]
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-07639 Filed 4-2-15; 8:45 am]
 BILLING CODE 4163-18-P

18244 Federal Register / Vol. 80, No. 64 / Friday, April 3, 2015 / Notices

DEPARTMENT OF HEALTH AND meaningfully advance drug The Director, Management Analysis
HUMAN SERVICES development. and Services Office, has been delegated
The current 60-day comment period the authority to sign Federal Register
Food and Drug Administration does not allow sufficient time to obtain notices pertaining to announcements of
the broad public response that will meetings and other committee
[Docket No. FDA–2014–N–2187] inform FDA’s Biomarker Qualification management activities for both the
Program going forward. FDA is Centers for Disease Control and
Identifying Potential Biomarkers for extending the comment period for an Prevention and the Agency for Toxic
Qualification and Describing Contexts additional 30 days, thus extending the Substances and Disease Registry.
of Use To Address Areas Important to comment period to May 15, 2015. The
Catherine Ramadei,
Drug Development; Extension of Agency believes that a 30-day extension
Comment Period allows adequate time for interested Acting Director, Management Analysis and
Services Office, Centers for Disease Control
persons to submit comments without and Prevention.
AGENCY: Food and Drug Administration, significantly delaying progress on these
HHS. important issues.
[FR Doc. 2015–07639 Filed 4–2–15; 8:45 am]

ACTION: Notice; extension of comment BILLING CODE 4163–18–P

period. II. Request for Comments
Interested persons may submit either
SUMMARY: The Food and Drug electronic comments regarding this
Administration (FDA) is extending the document to http://www.regulations.gov DEPARTMENT OF HOMELAND
comment period for the notice entitled or written comments to the Division of SECURITY
‘‘Identifying Potential Biomarkers for Dockets Management (see ADDRESSES). It
Qualification and Describing Contexts of United States Immigration and
is only necessary to send one set of
Use to Address Areas Important to Drug Customs Enforcement
comments. Identify comments with the
Development; Request for Comments’’ docket number found in brackets in the Agency Information Collection
that appeared in the Federal Register of heading of this document. Received Activities: Extension, With Change, of
February 13, 2015 (80 FR 8089). In the comments may be seen in the Division an Existing Information Collection;
notice, FDA requested comments on of Dockets Management between 9 a.m. Comment Request
identifying potential biomarkers for and 4 p.m., Monday through Friday, and
qualification and describing contexts of will be posted to the docket at http:// ACTION: 60-Day Notice of Information
use to address areas important to drug www.regulations.gov. collection for review; I–312/I–312A;
development. The Agency is taking this
Dated: March 30, 2015. Designation of Attorney in Fact/
action for an extension to allow
Leslie Kux, Revocation of Attorney In Fact; OMB
interested persons additional time to
Associate Commissioner for Policy. Control No. 1653–0041.
submit comments.
[FR Doc. 2015–07631 Filed 4–2–15; 8:45 am]
DATES: Submit either electronic or The Department of Homeland
BILLING CODE 4164–01–P
written comments by May 15, 2015 Security, U.S. Immigration and Customs
ADDRESSES: Submit electronic Enforcement (ICE), is submitting the
comments to http:// DEPARTMENT OF HEALTH AND following information collection request
www.regulations.gov. Submit written HUMAN SERVICES for review and clearance in accordance
comments to the Division of Dockets with the Paperwork Reduction Act of
Management (HFA–305), Food and Drug Centers for Disease Control and 1995. The information collection is
Administration, 5630 Fishers Lane, Rm. Prevention published in the Federal Register to
1061, Rockville, MD 20852. obtain comments from the public and
FOR FURTHER INFORMATION CONTACT:
Clinical Laboratory Improvement affected agencies. Comments are
Marianne Noone, Center for Drug Advisory Committee encouraged and will be accepted for
Evaluation and Research, Food and sixty days until June 2, 2015.
Correction: This notice was published
Drug Administration, 10903 New in the Federal Register on March 24, Written comments and suggestions
Hampshire Ave., Bldg. 21, Rm. 4528, 2015, Volume 80, Number 56, Pages regarding items contained in this notice
Silver Spring, MD 20993–0002, 301– 15621–15622. The times and dates and especially with regard to the
796–7495. should read as follows: estimated public burden and associated
Times and Dates: 12:30 p.m.—5:00 response time should be directed to the
SUPPLEMENTARY INFORMATION:
p.m., April 15, 2015; 8:30 a.m.—12:00 Department of Homeland Security
I. Background p.m., April 16, 2015. (DHS), Scott Elmore, Forms
Management Office, U.S. Immigration
In the Federal Register of February CONTACT PERSON FOR ADDITIONAL
and Customs Enforcement, 801 I Street
13, 2015 (80 FR 8089), FDA published INFORMATION: Nancy Anderson, Chief,
NW., Mailstop 5800, Washington, DC
a notice with a 60-day comment period Laboratory Practice Standards Branch,
20536–5800.
to request comments on identifying Division of Laboratory Programs,
asabaliauskas on DSK5VPTVN1PROD with NOTICES

potential biomarkers for qualification Standards, and Services, Center for Written comments and suggestions
and describing contexts of use to Surveillance, Epidemiology and from the public and affected agencies
address areas important to drug Laboratory Services, Office of Public concerning the proposed collection of
development. FDA is encouraging Health Scientific Services, CDC, 1600 information should address one or more
interested groups and individuals to Clifton Road NE., Mailstop F–11, of the following four points:
submit information on specific medical Atlanta, Georgia 30329–4018; telephone (1) Evaluate whether the proposed
and biological areas where novel (404) 498–2741; or via email at collection of information is necessary
biomarkers can be identified that would NAnderson@cdc.gov for the proper performance of the

VerDate Sep<11>2014 18:48 Apr 02, 2015 Jkt 235001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\03APN1.SGM 03APN1

Document Created: 2015-12-18 15:28:22
Document Modified: 2015-12-18 15:28:22

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		12:30 p.m.--5:00 p.m., April 15, 2015; 8:30 a.m.-- 12:00 p.m., April 16, 2015.
FR Citation		80 FR 18244

80 FR 18244 - Clinical Laboratory Improvement Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 64 (April 3, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention